PTGX
Companies
NASDAQ
Protagonist Therapeutics Inc.
Health Care
$54.44
+$15.84 (+41.04%)
Price Chart
Overview
About PTGX
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
Market Cap
$2.0B
Volume
69.1M
Avg. Volume
84.2M
P/E Ratio
-29.13986
Dividend Yield
0.00%
Employees
105.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.44
High Correlation
Volatility
High (0.80)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Low Sensitivity
GDP Growth
High Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, PTGX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$2.0B
Volume69.1M
P/E Ratio-29.14
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 21, 2025Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025